Profile Picture
Rewards
  • All
  • Chat
  • Images
  • Videos
  • Maps
  • News
  • More
    • Shopping
    • Flights
    • Travel
    • Hotels
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Politics
  • Business
  • interests

Trending on Bing

'Nice to be together'
7 shot, 2 dead in TN
Expecting first baby
5-yr-old kills brother
Highest tax burden
Refuses paper crown
Signs $4.5B deal
Pink diamond auction
Denies breaking law
'Thunderbolts' scribe
Trash strike ends
Smashing Pumpkins tour
Fire a homicide?
'I chose to survive'
James Beard Awards
Train derails in Minn.
Rangers re-sign Chytil
7 Calif. cops charged
RU arrests US reporter
Used cars in demand
On lockdown
School victims honored
'Gradually improving'
Returns to Brazil
Shark bites Colo. boy
Paid sick time off
Mara 'warns' Daboll
Lamborghini hybrid car
1st playoff berth
To slash 6% of staff
Max Fried injury
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days
  • Best match
    • Most recent
753 results
Pacbiztimes.com
13d
Amgen lays off another 450 workers
Amgen's new research and development facility in San Francisco. (courtesy photo) For the second time this year, Amgen is ...
Becker's Hospital Review13d
Amgen to lay off 450
Amgen, a drugmaker based in Thousand Oaks, Calif., will lay off 450 people — 2 percent of its workforce — with many separations occurring by May 26, according to a statement shared with Becker's.
9hon MSN
Amgen Options Traders Betting On Stock Rising This Much By April Expiration
Amgen Inc. (NASDAQ: AMGN) is expected to report quarterly earnings at $4 per share on revenue of $6.26 billion, analysts say.
Becker's Hospital Review2d
Digital therapeutics company lays off 35% of workforce
Better Therapeutics, a digital therapeutics company, laid off 35 percent of its workforce, according to a March 23 filing with the U.S. Securities and Exchange Commission. According to an end-of ...
Reuters2d
Amgen-Sanofi patent case divides makers of antibody drugs
March 27 (Reuters) - Amgen Inc's (AMGN.O) battle with Sanofi (SASY.PA) and Regeneron (REGN.O) at the U.S. Supreme Court over its cholesterol drug Repatha on Monday has some drugmakers hoping a ...
Wall Street Journal4d
Amgen Seeks to Monopolize Nature
On Monday the Supreme Court will hear oral arguments in Amgen v. Sanofi, a case with immense potential consequences for scientific innovation. If the high court upends settled patent law by ...
3don MSN
Amgen bid to revive cholesterol drug patents comes to U.S. Supreme Court
The U.S. Supreme Court on Monday is set to hear a bid by Amgen Inc to revive patents on its cholesterol-lowering drug Repatha in a legal effort that rival Sanofi SA called a "blatant attempt" to ...
Computing1d
Twilio lays off 930 employees: 5 big things to know
Twilio is laying off nearly 1,000 employees, as the cloud communications specialist says it simply grew too fast and needs to focus on profitability and core priorities. However, some of the sta ...
CNBC7d
Walmart lays off hundreds of workers at e-commerce facilities
Walmart is laying off hundreds of employees at e-commerce fulfillment centers across the country. The big-box giant joins a growing list of retailers, including Amazon and Target, that are cutting ...
Business Insider7d
Influencer-marketing platform Grin lays off staffers across marketing, engineering, and more teams: 'Unfair and unexpected'
Grin, a marketing platform used by brands to run sponsored campaigns with influencers on social media, is the latest creator-economy startup to lay off employees. On Tuesday, the company laid off ...
Yahoo Finance2d
Amgen-Sanofi patent case divides makers of antibody drugs
March 27 (Reuters) - Amgen Inc's battle with Sanofi and Regeneron at the U.S. Supreme Court over its cholesterol drug Repatha on Monday has some drugmakers hoping a ruling will reshape U.S. patent ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results
© 2023 Microsoft
  • Privacy and Cookies
  • Legal
  • Advertise
  • About our ads
  • Help
  • Feedback